Dr. Khoa Ngo, DO
NPI: 1710379425
Total Payments
$13,532
2024 Payments
$11,754
Companies
13
Transactions
48
Medicare Patients
1,257
Medicare Billing
$142,206
Payment Breakdown by Category
Consulting$6,606 (48.8%)
Other$4,675 (34.5%)
Food & Beverage$2,250 (16.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,606 | 9 | 48.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,675 | 3 | 34.5% |
| Food and Beverage | $2,250 | 36 | 16.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $8,125 | 11 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $2,627 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $1,174 | 2 | $0 (2024) |
| ABBVIE INC. | $271.46 | 4 | $0 (2023) |
| GlaxoSmithKline, LLC. | $266.60 | 11 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $235.11 | 2 | $0 (2022) |
| PFIZER INC. | $211.13 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $141.40 | 3 | $0 (2017) |
| Celgene Corporation | $125.00 | 1 | $0 (2017) |
| Mallinckrodt LLC | $120.39 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,754 | 17 | Amgen Inc. ($8,097) |
| 2023 | $346.40 | 5 | ABBVIE INC. ($193.66) |
| 2022 | $383.39 | 10 | Boehringer Ingelheim Pharmaceuticals, Inc. ($124.50) |
| 2021 | $11.36 | 1 | GlaxoSmithKline, LLC. ($11.36) |
| 2020 | $53.57 | 1 | AbbVie Inc. ($53.57) |
| 2019 | $242.44 | 3 | GlaxoSmithKline, LLC. ($131.83) |
| 2018 | $159.32 | 4 | PFIZER INC. ($120.68) |
| 2017 | $580.98 | 7 | AstraZeneca Pharmaceuticals LP ($141.40) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Consulting Fee | Cash or cash equivalent | $957.00 | General |
| Category: Not Applicable | ||||||
| 10/16/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Consulting Fee | Cash or cash equivalent | $247.50 | General |
| Category: Not Applicable | ||||||
| 09/04/2024 | Amgen Inc. | TAVNEOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $124.46 | General |
| Category: Inflammation | ||||||
| 08/22/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $825.00 | General |
| 08/22/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $99.08 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Consulting Fee | Cash or cash equivalent | $660.00 | General |
| Category: Not Applicable | ||||||
| 06/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Immunology | ||||||
| 06/18/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Inflammation | ||||||
| 05/20/2024 | Amgen Inc. | TAVNEOS (Drug) | Consulting Fee | Cash or cash equivalent | $2,359.50 | General |
| Category: Inflammation | ||||||
| 05/09/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Consulting Fee | Cash or cash equivalent | $330.00 | General |
| Category: Not Applicable | ||||||
| 05/07/2024 | Amgen Inc. | TAVNEOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Inflammation | ||||||
| 04/29/2024 | Amgen Inc. | TAVNEOS (Drug) | Consulting Fee | Cash or cash equivalent | $589.88 | General |
| Category: Inflammation | ||||||
| 04/25/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Consulting Fee | Cash or cash equivalent | $247.50 | General |
| Category: Not Applicable | ||||||
| 04/25/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Consulting Fee | Cash or cash equivalent | $165.00 | General |
| Category: Not Applicable | ||||||
| 04/10/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: Inflammation | ||||||
| 02/13/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Inflammation | ||||||
| 12/14/2023 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological) | Food and Beverage | In-kind items and services | $124.10 | General |
| Category: Immunology | ||||||
| 12/07/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: IMMUNOLOGY | ||||||
| 04/13/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $68.67 | General |
| Category: IMMUNOLOGY | ||||||
| 03/08/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2022 | Janssen Scientific Affairs, LLC | TREMFYA (Drug), SIMPONI ARIA, STELARA | Food and Beverage | In-kind items and services | $120.32 | General |
| Category: Immunology | ||||||
| 11/09/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: WOMENS HEALTH | ||||||
| 11/03/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.50 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 409 | 524 | $187,950 | $44,417 |
| 2022 | 11 | 422 | 588 | $215,684 | $48,923 |
| 2021 | 9 | 373 | 532 | $164,075 | $44,768 |
| 2020 | 1 | 53 | 62 | $17,086 | $4,098 |
Total Patients
1,257
Total Services
1,706
Medicare Billing
$142,206
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 91 | 127 | $54,793 | $12,293 | 22.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 48 | $20,112 | $4,967 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 72 | 75 | $21,994 | $4,816 | 21.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 80 | $17,120 | $4,725 | 27.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 40 | $12,360 | $3,620 | 29.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 24 | 24 | $13,092 | $3,136 | 24.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $11,381 | $2,404 | 21.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $9,181 | $2,234 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 25 | $6,550 | $1,864 | 28.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 15 | $6,060 | $1,493 | 24.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 16 | 20 | $7,660 | $1,376 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 20 | $3,853 | $850.01 | 22.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 14 | 14 | $3,794 | $638.10 | 16.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 97 | 155 | $68,327 | $15,341 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 83 | 102 | $30,340 | $6,824 | 22.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 83 | $25,647 | $6,527 | 25.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 42 | 42 | $23,106 | $5,216 | 22.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 34 | $20,366 | $5,210 | 25.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 27 | 27 | $10,908 | $2,836 | 26.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 41 | $8,774 | $2,273 | 25.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 33 | 35 | $13,405 | $2,108 | 15.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 28 | 31 | $8,401 | $1,260 | 15.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 21 | 25 | $5,142 | $1,002 | 19.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 12 | 13 | $1,268 | $326.62 | 25.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 37 | 134 | $41,406 | $10,803 | 26.1% |
About Dr. Khoa Ngo, DO
Dr. Khoa Ngo, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/04/2015. The National Provider Identifier (NPI) number assigned to this provider is 1710379425.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khoa Ngo, DO has received a total of $13,532 in payments from pharmaceutical and medical device companies, with $11,754 received in 2024. These payments were reported across 48 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($6,606).
As a Medicare-enrolled provider, Ngo has provided services to 1,257 Medicare beneficiaries, totaling 1,706 services with total Medicare billing of $142,206. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Rheumatology
- Location Albany, NY
- Active Since 03/04/2015
- Last Updated 01/29/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710379425
Products in Payments
- TAVNEOS (Drug) $7,272
- Arcalyst (Drug) $2,627
- TREMFYA (Drug) $1,170
- BENLYSTA (Biological) $266.60
- RINVOQ (Biological) $193.66
- ELIQUIS (Drug) $192.17
- Otezla (Drug) $125.00
- SIMPONI ARIA (Biological) $124.10
- ACTHAR (Biological) $120.39
- OFEV (Drug) $110.61
- XARELTO (Drug) $103.74
- RINVOQ (Drug) $53.57
- Enbrel (Biological) $27.26
- LILETTA (Drug) $24.23
- BRILINTA (Drug) $19.00
- XELJANZ (Drug) $18.96
- JANUVIA (Drug) $11.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Albany
Anuj Malhotra, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $224,738
Student in an Organized Health Care Education/Training Program $224,738
Dr. Erica Parrotta, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $111,723
Student in an Organized Health Care Education/Training Program $111,723
William Raible, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $42,671
Student in an Organized Health Care Education/Training Program $42,671
Dr. Olumayowa Abiodun, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $33,199
Student in an Organized Health Care Education/Training Program $33,199
Dr. Alexandra Paul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $15,462
Student in an Organized Health Care Education/Training Program $15,462
Dr. Sridhar Musuku, M.d Frca, M.D FRCA
Student in an Organized Health Care Education/Training Program — Payments: $14,736
Student in an Organized Health Care Education/Training Program $14,736